Medicare Enrolled
Dr. Philip Otterbeck, M.D.
Endocrinology · Staten Island, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Otterbeck from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Otterbeck?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Otterbeck
Dr. Philip Otterbeck is an endocrinology specialist in Staten Island, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Otterbeck performed 1,530 Medicare services across 1,095 unique beneficiaries.
Between the years covered by Open Payments, Dr. Otterbeck received a total of $593,725 from 76 pharmaceutical and/or device companies across 2286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Otterbeck is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 31% volume in NY
$593,725 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,530
Medicare services
Top 31% in NY for endocrinology
1,095
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~85 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
798 | $105 | $223 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
423 | $68 | $153 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
102 | $8 | $25 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
83 | $84 | $244 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
51 | $47 | $80 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
26 | $73 | $147 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $122 | $279 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
17 | $120 | $630 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $158 | $339 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$593,725
Total received (2018-2024)
Avg $84,818/year across 7 years
Top 1% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
2,286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$565,631 (95.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,571 (3.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,522 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$76,274
2023
$58,498
2022
$119,278
2021
$64,587
2020
$51,647
2019
$114,002
2018
$109,439
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$35,255
Novo Nordisk Inc
$18,112
AstraZeneca Pharmaceuticals LP
$14,513
Intra-Sana Laboratories
$5,443
Amgen Inc.
$518
Corcept Therapeutics
$418
Amneal Pharmaceuticals LLC
$293
Bayer Healthcare Pharmaceuticals Inc.
$210
Boehringer Ingelheim Pharmaceuticals, Inc.
$202
SANOFI-AVENTIS U.S. LLC
$180
Novartis Pharmaceuticals Corporation
$174
ABBVIE INC.
$166
Abbott Laboratories
$134
Xeris Pharmaceuticals, Inc.
$84
Esperion Therapeutics, Inc.
$82
Dexcom, Inc.
$56
Insulet Corporation
$50
IBSA Pharma Inc.
$45
Astellas Pharma US Inc
$45
PFIZER INC.
$39
Chiesi USA, Inc.
$29
CeQur Corporation
$28
Alexion Pharmaceuticals, Inc.
$27
Neurocrine Biosciences, Inc.
$26
Averitas Pharma Inc.
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Tandem Diabetes Care, Inc.
$23
Acella Pharmaceuticals, LLC
$21
Echosens North America, Inc.
$20
Currax Pharmaceuticals LLC
$17
Melinta Therapeutics, LLC
$14
Top 3 companies account for 89.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$222,288
AstraZeneca Pharmaceuticals LP
$112,072
Lilly USA, LLC
$100,802
Merck Sharp & Dohme Corporation
$29,600
Boehringer Ingelheim Pharmaceuticals, Inc.
$22,480
SANOFI-AVENTIS U.S. LLC
$20,453
Esperion Therapeutics, Inc.
$19,750
Janssen Pharmaceuticals, Inc
$18,089
Bayer HealthCare Pharmaceuticals Inc.
$13,253
Bayer Healthcare Pharmaceuticals Inc.
$9,022
Intra-Sana Laboratories
$5,483
VistaPharm, Inc.
$2,298
Amgen Inc.
$2,003
Medtronic, Inc.
$1,710
Amneal Pharmaceuticals LLC
$1,446
Corcept Therapeutics
$1,352
Insulet Corporation
$1,230
Amarin Pharma Inc.
$1,036
Dexcom, Inc.
$1,022
Kowa Pharmaceuticals America, Inc.
$767
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$720
ABBVIE INC.
$543
Abbott Laboratories
$515
PFIZER INC.
$508
Medtronic MiniMed, Inc.
$474
GRT US Holding, Inc.
$425
Xeris Pharmaceuticals, Inc.
$369
AbbVie Inc.
$295
Currax Pharmaceuticals LLC
$233
Novartis Pharmaceuticals Corporation
$215
Tandem Diabetes Care, Inc.
$166
Ipsen Biopharmaceuticals, Inc
$165
Shire North American Group Inc
$164
EISAI INC.
$161
Neurocrine Biosciences, Inc.
$146
IBSA Pharma Inc.
$140
Mannkind Corporation
$137
Gemini Laboratories, LLC
$132
Valeritas, Inc.
$125
Radius Health, Inc.
$122
Janssen Scientific Affairs, LLC
$120
Amryt Pharma Holdings Ltd
$111
Merck Sharp & Dohme LLC
$109
MannKind Corporation
$100
LifeScan, Inc.
$98
Horizon Therapeutics plc
$94
Becton, Dickinson and Company
$91
DEXCOM, INC.
$89
Regeneron Healthcare Solutions, Inc.
$88
Astellas Pharma US Inc
$88
AbbVie, Inc.
$77
RECORDATI_RARE_DISEASES_INC.
$73
Eisai Inc.
$53
Kyowa Kirin, Inc.
$49
Embecta Corp.
$43
Zealand Pharma US, Inc.
$40
Antares Pharma, Inc.
$37
Nalpropion Pharmaceuticals LLC
$36
Ultragenyx Pharmaceutical Inc.
$35
Echosens North America, Inc.
$33
Chiesi USA, Inc.
$29
CeQur Corporation
$28
Orexigen Therapeutics, Inc.
$27
Alexion Pharmaceuticals, Inc.
$27
Averitas Pharma Inc.
$25
Nalpropion Pharmaceuticals, Inc.
$25
Acerus Pharmaceuticals Corporation
$24
Clarus Therapeutics Inc.
$24
Lexicon Pharmaceuticals, Inc.
$23
Amphastar Pharmaceuticals, Inc.
$22
Acella Pharmaceuticals, LLC
$21
LIFESCAN, INC.
$21
Azurity Pharmaceuticals, Inc.
$16
Allergan Inc.
$15
Melinta Therapeutics, LLC
$14
Strongbridge US INC.
$14
Top 3 companies account for 73.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · Aimovig · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · BYSTOLIC · Belviq · CONTRAVE · CRYSViTA · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · Cryvista · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LEQVIO · LICART · LINQ II · LOKELMA · LYRICA · LYUMJEV · Livalo · MACRILEN · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · NP Thyroid 60 · Natesto · Norditropin · NovoLog · ONGENTYS · Omnipod · OneTouch · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QUTENZA · Qutenza · RAYOS · RECORLEV · RELTONE 200 MG · RELTONE 400 MG · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Seglentis · Signia · Sogroya · Synthroid · TEFLARO · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · V-GO · VERQUVO · Vabomere · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xermelo · Xultophy 100/3.6 · ZEGALOGUE · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for endocrinology in NY.
Geographic Context
Endocrinologists within 10 mi
664
Per 100K population
134.8
County median income
$98,290
Nearest hospital
RICHMOND UNIVERSITY MEDICAL CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Otterbeck is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Otterbeck experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Otterbeck performed 798 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Otterbeck receive payments from pharmaceutical companies?
Yes. Dr. Otterbeck received a total of $593,725 from 76 companies across 2,286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Otterbeck's costs compare to other endocrinologists in Staten Island?
Dr. Otterbeck's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Otterbeck) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Staten Island
Browse endocrinologists in Staten Island ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology